In an attempt to find a serological marker for the diagnosis of chronic digestive forms of Chagas' disease, we compared amastigote and trypomastigote antigens obtained from immunosuppressed mice infected with Trypanosoma cruzi (Y strain) with conventional epimastigote antigens to search for immunoglobulin A (IgA) antibodies. A total of 255 serum samples from patients with acute and chronic (indeterminate, digestive, and cardiac) forms of Chagas' disease and with nonchagasic diseases and from healthy individuals were studied. Amastigote antigens proved to be the most adequate for our purpose, since IgA antibodies could be detected in 23 of 25 serum samples from patients with digestive forms, with relative indices of sensitivity, specificity, and efficiency of 0.920, 0.911, and 0.912, respectively. These antigens also showed high reactivity with IgA antibodies, with a geometric mean titer of 16,635 (12.7 log2). IgA antibodies were detected in 16 of 28 serum samples from patients with the acute form as well, but this clinical form is easily distinguished from the chronic form by the demonstration of IgM antibodies. Poor results were seen with trypomastigote and epimastigote antigens. The finding of IgA antibodies in about 20% of indeterminate forms and 20% of cardiac forms, although in low titers, requires further investigation to ascertain their role as an early signal of gastrointestinal lesions. In addition, the amastigote antigens described here seem more convenient for use in endemic areas than those obtained from cell cultures because of their lower cost.
In areas in which Chagas' disease is endemic, digestive forms either associated with or not associated with myocardiopathies have been reported to occur in about 7 to 14% of the chronic cases (7, 17, 18) . Radiologic diagnosis is of limited sensitivity, since it detects severe or moderate but not earlier phases of gastrointestinal dilatations. For this purpose, more sensitive methods are therefore required (18) . Present serological tests, although very suitable for the diagnosis of Trypanosoma cruzi infections, provide no information on pathological differences among chronic forms of the disease (6, 13) . In digestive forms, Ferreira et al. (11) found increased levels of total immunoglobulin A (IgA) in serum, but specific IgA antibodies could be detected in only about one-half of the cases by an immunofluorescence (IF) test with T. cruzi epimastigotes as antigens. Antigenic differences have been demonstrated between life cycle stages of T. cruzi (15) . Trypomastigotes have been shown to be useful for the demonstration of lytic antibodies, which are considered markers of active infections (16) . However, in an IF test, amastigotes have been found to be more reactive than other parasite stages (8, 10 Serological tests for Chagas' disease. All sera were assayed by complement fixation, IF for IgG antibody, and indirect HA tests for Chagas' disease as described previously (5 7 postinfection, at the peak of parasitemia, by heart puncture, defibrinated with glass beads, centrifuged at 1,000 x g for 1 min at room temperature, and left for 10 min at 37°C before removal of the supernatant plasma. This plasma, rich in parasites, was then centrifuged at 1,000 x g for 15 min at 4°C. Sedimented trypanosomes were washed twice in medium 199 (GIBCO Laboratories) with 1% bovine serum albumin (fraction V; Sigma Chemical Co.). Parasites were then processed as described for epimastigotes (4) . Intracellular amastigotes were taken from the spleen and liver of infected mice, purified by two-step discontinuous gradient centrifugation as described previously (1), and processed as described for epimastigotes (4 Our purpose was to define an immunological marker for the digestive forms of Chagas' disease. Cutoff titers (Fig. 1) were established for each test to separate, with the highest possible efficiency, patients with digestive forms from patients with all other chronic forms of Chagas' disease, other infections, and no infections (normal individuals). Patients with acute forms were not included in either group since, although they have IgA-reactive antibodies, they can be distinguished from patients with other forms of Chagas' disease because they have anti-T. cruzi IgM antibodies in their sera. Figure 2 depicts the frequency of titers for both groups in the IgA IF test with amastigotes. The best cutoff observed between the left curve corresponding to the digestive forms and the right curve corresponding to all other forms except for acute forms is also shown. Table 1 indicates sensitivity, specificity, and efficiency indices for the selected cutoffs. As shown in Fig. 1 and 3 In the IgA IF tests with epimastigotes and trypomastigotes, much lower titers were seen, and no significant differences were observed among individuals with the different forms of Chagas' disease and nonchagasic individuals. Table 2 indicates the reactivities seen for serum samples from patients in the several groups studied in relation to the established cutoffs.
DISCUSSION
The data presented here show a close positive correlation between the digestive forms of chronic Chagas' disease and high titers of antiamastigote IgA antibodies in serum. Titers between 2,560 and 655,360 were seen in 23 of 25 cases, with a GMT of 16,635.
In patients with digestive tract involvement, the finding of IgA antibodies in serum seems to be significant and might constitute an early signal of active mucosal lesions of, for example, mucocutaneous leishmaniasis (12, 21) and mycoses with mucous membrane or respiratory tract implications (3). However, specific IgA antibodies in serum are not observed in advanced cases of mucocutaneous leishmaniasis with a long history of destructive lesions (12) . The persistence of IgA antibodies in the digestive forms of chronic Chagas' disease is thus an unexpected finding. Although present in lower titers, antiamastigote IgA antibodies were also observed in significant titers in about 20% of patients with indeterminate forms. These patients should be closely monitored to verify whether the disease will progress with the onset of digestive disturbances. For the cardiac form, about 20% of the patients were also positive for antiamastigote IgA antibodies; a few already had digestive impairment.
Amastigote antigens proved to be much more sensitive for revealing IgA antibodies than the other T. cruzi antigens. Amastigotes from T. cruzi-infected mice were not only easier to obtain but also had a higher reactivity than those from cell cultures (2) . In tests with the former, serum samples were previously absorbed with mouse liver and kidney powders to avoid possible interference by animal tissue components.
The presence of IgA antibodies in the acute phase of Chagas' disease, as observed here, was an expected finding, since these class-specific antibodies have pathogenic signif- icance and diagnostic value in several nonrelated acute infections (12, 19, 20) . The results shown in Table 2 
